Evaluation of the DoD’s Efforts to Implement FY 2024 National Defense Authorization Act Requirements for Fentanyl (Report No. DODIG-2026-068)
/ Published March 11, 2026
What We Did:
The objective of this evaluation was to determine the extent to which the DoD and Military Departments (MILDEPs) progressed toward: (1) having naloxone available on all military installations and in operational environments and (2) establishing a standardized tracking system for naloxone distribution and Service members’ illegal use of fentanyl